{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T04:50:40Z","timestamp":1793767840345,"version":"4.6.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008318","name":"Spanish Association for the Study of the Liver","doi-asserted-by":"publisher","award":["Juan Cordoba"],"award-info":[{"award-number":["Juan Cordoba"]}],"id":[{"id":"10.13039\/100008318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI21\/01995"],"award-info":[{"award-number":["PI21\/01995"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI20\/01258"],"award-info":[{"award-number":["PI20\/01258"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/j.jhep.2024.12.017","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T11:58:36Z","timestamp":1734436716000},"page":"70-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis"],"prefix":"10.1016","volume":"83","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5255-9445","authenticated-orcid":false,"given":"Jose Ignacio","family":"Fortea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2036-6133","authenticated-orcid":false,"given":"Edilmar","family":"Alvarado-Tapias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedikt","family":"Simbrunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5115-1878","authenticated-orcid":false,"given":"Iranzu","family":"Ezcurra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia","family":"Hern\u00e1ndez-Gea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carles","family":"Aracil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6612-7501","authenticated-orcid":false,"given":"Elba","family":"Llop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Puente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Roig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4590-3583","authenticated-orcid":false,"given":"Thomas","family":"Reiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9032-4954","authenticated-orcid":false,"given":"Juan Carlos","family":"Garc\u00eda-Pagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Calleja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreu","family":"Ferrero-Gregori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Mandorfer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Candid","family":"Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2024.12.017_bib1","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1097\/HEP.0000000000000647","article-title":"AASLD Practice Guidance on risk stratification and management of portal hypertension and varices in cirrhosis","volume":"79","author":"Kaplan","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.12.017_bib2","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.12.017_bib3","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.cgh.2019.05.050","article-title":"Lowering portal pressure improves outcomes of patients with cirrhosis, with or without ascites: a meta-analysis","volume":"18","author":"Turco","year":"2020","journal-title":"Clin Gastroenterol Hepatol : official Clin Pract J Am Gastroenterological Assoc"},{"key":"10.1016\/j.jhep.2024.12.017_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1053\/j.gastro.2009.03.048","article-title":"Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding","volume":"137","author":"Villanueva","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2024.12.017_bib5","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/hep4.2021","article-title":"Acute hemodynamic response to propranolol predicts bleeding and nonbleeding decompensation in patients with cirrhosis","volume":"6","author":"Hofer","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2024.12.017_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.jhep.2009.04.015","article-title":"Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension","volume":"51","author":"La Mura","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.12.017_bib7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2020.03.048","article-title":"Short-term hemodynamic effects of \u03b2-blockers influence survival of patients with decompensated cirrhosis","volume":"73","author":"Alvarado-Tapias","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.12.017_bib8","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"Beta blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2024.12.017_bib9","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jhep.2022.05.021","article-title":"Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis","volume":"77","author":"Villanueva","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.12.017_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/apt.17824","article-title":"Improving primary prophylaxis of variceal bleeding by adapting therapy to the clinical stage of cirrhosis. A competing-risk meta-analysis of individual participant data","volume":"59","author":"Villanueva","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2024.12.017_bib11","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/hep.30220","article-title":"Comparison of therapies for primary prevention of esophageal variceal bleeding: a systematic review and network meta-analysis","volume":"69","author":"Sharma","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.12.017_bib12","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/hep.29267","article-title":"Stratifying risk in the prevention of recurrent variceal hemorrhage: results of an individual patient meta-analysis","volume":"66","author":"Albillos","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.12.017_bib13","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.jhep.2020.05.011","article-title":"Non-selective beta-blockers impair global circulatory homeostasis and renal function in cirrhotic patients with refractory ascites","volume":"73","author":"T\u00e9llez","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.12.017_bib14","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1136\/gutjnl-2012-304038","article-title":"Carvedilol for primary prophylaxis of variceal bleeding in cirrhotic patients with haemodynamic non-response to propranolol","volume":"62","author":"Reiberger","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.12.017_bib15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.12998\/wjcc.v6.i13.611","article-title":"Impact of an acute hemodynamic response-guided protocol for primary prophylaxis of variceal bleeding","volume":"6","author":"Fortea","year":"2018","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.jhep.2024.12.017_bib16","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1016\/j.cgh.2022.06.007","article-title":"Carvedilol achieves higher hemodynamic response and lower rebleeding rates than propranolol in secondary prophylaxis","volume":"21","author":"Jachs","year":"2023","journal-title":"Clin Gastroenterol Hepatol : official Clin Pract J Am Gastroenterological Assoc"},{"key":"10.1016\/j.jhep.2024.12.017_bib17","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/hep.1840360612","article-title":"Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis","volume":"36","author":"Banares","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2024.12.017_bib18","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12072-016-9765-y","article-title":"Carvedilol versus propranolol effect on hepatic venous pressure gradient at 1 month in patients with index variceal bleed: RCT","volume":"11","author":"Gupta","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2024.12.017_bib19","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1038\/ajg.2016.327","article-title":"A randomized, multi-center, open-label study to evaluate the efficacy of carvedilol vs. Propranolol to reduce portal pressure in patients with liver cirrhosis","volume":"111","author":"Kim","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2024.12.017_bib20","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/apt.12634","article-title":"Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis","volume":"39","author":"Sinagra","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2024.12.017_bib21","article-title":"Carvedilol versus traditional, non-selective beta-blockers for adults with cirrhosis and gastroesophageal varices","volume":"10","author":"Zacharias","year":"2018","journal-title":"Cochrane database Syst Rev"},{"key":"10.1016\/j.jhep.2024.12.017_bib22","first-page":"287","article-title":"Carvedilol for prevention of variceal bleeding: a systematic review and meta-analysis","volume":"32","author":"Malandris","year":"2019","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.jhep.2024.12.017_bib23","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1136\/gutjnl-2016-312129","article-title":"Beta-blockers in patients with cirrhosis and ascites: type of beta-blocker matters","volume":"65","author":"Njei","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.jhep.2024.12.017_bib24","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jhep.2017.02.005","article-title":"Carvedilol use is associated with improved survival in patients with liver cirrhosis and ascites","volume":"67","author":"Sinha","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2024.12.017_bib25","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/apt.16189","article-title":"Carvedilol is associated with improved survival in patients with cirrhosis: a long-term follow-up study","volume":"53","author":"McDowell","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2024.12.017_bib26","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jceh.2020.08.009","article-title":"Long-term outcomes with carvedilol versus propranolol in patients with index variceal bleed: 6-year follow-up study","volume":"11","author":"Sharma","year":"2021","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.jhep.2024.12.017_bib27","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/MCG.0000000000001431","article-title":"Conversion of propranolol to carvedilol improves renal perfusion and outcome in patients with cirrhosis and ascites","volume":"55","author":"Kalambokis","year":"2021","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/j.jhep.2024.12.017_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s12072-017-9835-9","article-title":"Efficacy of carvedilol versus propranolol versus variceal band ligation for primary prevention of variceal bleeding","volume":"12","author":"Abd ElRahim","year":"2018","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jhep.2024.12.017_bib29","article-title":"Primary prevention of variceal bleeding in people with oesophageal varices due to liver cirrhosis: a network meta-analysis","volume":"4","author":"Roccarina","year":"2021","journal-title":"Cochrane database Syst Rev"},{"key":"10.1016\/j.jhep.2024.12.017_bib30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/s13063-024-08063-3","article-title":"Beta-blockers or Placebo for Primary Prophylaxis (BOPPP) of oesophageal varices: study protocol for a randomised controlled trial","volume":"25","author":"Patel","year":"2024","journal-title":"Trials"},{"key":"10.1016\/j.jhep.2024.12.017_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2019-000290","article-title":"Study protocol for a randomised controlled trial of carvedilol versus variceal band ligation in primary prevention of variceal bleeding in liver cirrhosis (CALIBRE trial)","volume":"6","author":"Tripathi","year":"2019","journal-title":"BMJ Open Gastroenterol"},{"key":"10.1016\/j.jhep.2024.12.017_bib32","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1136\/gutjnl-2023-331181","article-title":"Combination of carvedilol with variceal band ligation in prevention of first variceal bleed in Child-Turcotte-Pugh B and C cirrhosis with high-risk oesophageal varices: the \u2018CAVARLY TRIAL\u2019","volume":"73","author":"Tevethia","year":"2024","journal-title":"Gut"}],"updated-by":[{"DOI":"10.1016\/j.jhep.2025.08.004","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000}}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824027727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827824027727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T01:05:48Z","timestamp":1766192748000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827824027727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S0168827824027727"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2024.12.017","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carvedilol vs. propranolol for the prevention of decompensation and mortality in patients with compensated and decompensated cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2024.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 European Association for the Study of the Liver. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}